CAS: 221698-39-1; 4-Chloro-6,7-Dimethoxyquinazolin-2-Amine

该化合物是一种五氯硝基苯衍生物,在制药和有机合成方面有很大用途,其氯和角氧功能组增强了反应性,使其成为发展动脉抑制剂和其他生物活性化合物的多用途中间体.该化合物在标准条件下的稳定性确保了可靠的处理和储存.其高纯度和定义明确的结构有利于药用化学应用的精确修改.研究人员认为该化合物在建立复杂的血循环框架,特别是在抗癌和抗微生物药物发现方面的作用是有价值的.由于存在电子施食(methoxy)和电吸食(clocro)组,因此能够定制合成途径,优化产量和选择目标合成.

结构式图片

上下游产品

2-amino-6,7-dimethoxyquinolizin-4(3H)-one methyl 2-amino-4,5-dimethoxybenzoate

合成工艺路线路线简述

    📜2-氨基-4,5-二甲氧基苯甲酸甲酯置于盐酸,三氯氧磷体系中,用 1,4-二氧六环 用作溶剂,化学反应 15.5H,反应生成4-氯-6,7-二甲氧基-喹唑啉-2-胺
    参考文献:Tyrosine Kinase Inhibitors. 8. An Unusually Steep Structure−activity Relationship For Analogues Of 4-(3-Bromoanilino)-6,7-Dimethoxyquinazoline (Pd 153035),A Potent Inhibitor Of The Epidermal Growth Factor Receptor
    标题:Tyrosine Kinase Inhibitors. 8. An Unusually Steep Structure−activity Relationship For Analogues Of 4-(3-Bromoanilino)-6,7-Dimethoxyquinazoline (Pd 153035),A Potent Inhibitor Of The Epidermal Growth Factor Receptor
    摘要:4-(3-Bromoanilino)-6,7-Dimethoxyquinazoline (32,Pd 153035) Is A Very Potent Inhibitor (Ic50 0.025 Nm) Of The Tyrosine Kinase Activity Of The Epidermal Growth Factor Receptor (Egfr),Binding Competitively At The Atp Site. Structure-Activity Relationships For Close Analogues Of 32 Are Very Steep. Some Derivatives Have Ic(50)S Up To 80-Fold Better Than Predicted From Simple Additive Binding Energy Arguments,Yet Analogues Possessing Combinations Of Similar Phenyl And Quinazoline Substituents Do Not Show This ''Supra-Additive'' Effect. Because Some Substituents Which Are Mildly Deactivating By Themselves Can Be Strongly Activating When Used In The Correct Combinations,It Is Proposed That Certain Substituted Analogues Possess The Ability To Induce A Change In The Conformation Of The Receptor When They Bind. There Is Some Bulk Tolerance For Substitution In The 6-And 7-Positions Of The Quinazoline,So That 32 Is Not The Optimal Inhibitor For The Induced Conformation. The Diethoxy Derivative 56 [4-(3-Bromoanilino)-6,7-Diethoxyquinazoline] Shows An Ic50 Of 0.006 Nm,Making It The Most Potent Inhibitor Of The Tyrosine Kinase Activity Of The Egfr Yet Reported.
    Doi:10.1021/jm9503613

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献

    参考DOI号:10.1021/jm9503613
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知